Company Filing History:
1 out of 832,843 Years Active: 1979
Title: Eliezer Kaplinsky: Innovator in Antiarrhythmic Compounds
Introduction
Eliezer Kaplinsky is an accomplished inventor based in Tel Hashomer, Israel. He is recognized for his significant contributions to the field of pharmacology, particularly in the development of antiarrhythmic compounds. With one patented invention to his name, Kaplinsky has made notable strides in the medical research community.
Latest Patents
Kaplinsky holds a patent for an innovative compound known as the Antiarrhythmic Quinuclidine Carboxylic Acid Xylidide. This invention relates to the compound 2-6-xylidide of quinuclidine-3-carboxylic acid and its pharmaceutically acceptable salts, including hydrochloride. The compound has been identified as an effective antiarrhythmic agent, demonstrating significant potential in medical applications. Furthermore, the patent covers the method of producing this antiarrhythmic compound, which can also be adapted to create other related compounds, although they may not exhibit antiarrhythmic properties. The production method involves the reaction of quinuclidine carboxylic acid in anhydrous chloroform and oxalyl chloride with dimethylaniline, yielding a high-purity product.
Career Highlights
Throughout his career, Kaplinsky has focused on advancing pharmaceutical innovations. His patent for the antiarrhythmic agent showcases his expertise and dedication to finding solutions in medical science. This feather in his cap marks him as a valuable contributor to the field.
Collaborations
During his career, Eliezer Kaplinsky has collaborated with notable professionals in the industry, including colleagues Edna Oppenheimer and Sasson Cohen. These partnerships have played a significant role in his work, facilitating the sharing of ideas and resources that are crucial for innovation.
Conclusion
Eliezer Kaplinsky stands out as a prominent inventor with his work in the development of antiarrhythmic compounds. His patented invention underscores the impact that dedicated researchers can have on healthcare. As innovations continue to evolve, Kaplinsky's contributions will undoubtedly play a part in advancing medical treatments for arrhythmias and similar conditions.